Iranian researchers from five scientific and medical institutions have designed a novel mRNA vaccine candidate using advanced computational methods that could potentially prevent the growth and spread of breast cancer tumors.

Iran joins elite ADC-producing countries with Tederox and Padynex, cutting costs by over 90 percent, expanding HER2-positive cancer treatment access, and showcasing rapid biopharmaceutical advancement despite sanctions.

An endoscopic eardrum repair surgery was successfully performed for the first time in Iran’s western province of Kermanshah at Imam Reza Hospital Complex.

An Iranian knowledge-based company has developed a rapid nano-diagnostic kit capable of detecting Helicobacter pylori—the leading preventable cause of stomach cancer—with high accuracy and without the need for invasive procedures.

Iran has consolidated its position among the world’s top five countries in regenerative medicine, as a series of major biotechnology and healthcare projects backed by the Vice Presidency for Science, Technology and Knowledge-Based Economy and private-sector partners approach completion.

Iran ranks fourth globally in high-impact research on advanced aircraft engines, including hypersonic propulsion, reflecting a focused, sanctions-resistant scientific strategy that has positioned it ahead of several traditional aerospace powers.

Iran is expected to begin human trials of its domestically developed deep brain stimulation (DBS) technology by the Iranian year 1406 (March 2027–March 2028), according to a senior official involved in the national project.